Clinical Trial Update: Carmustine in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating Carmustine for progressive or recurrent glioblastoma multiforme.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Carmustine (carmustine)

Snippet

Sponsor: Direct Therapeutics | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: UNKNOWN